BIORELIX INC has a total of 29 patent applications. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are AVENTIS PHARMA SA, RHIZEN PHARMACEUTICALS S A and AMURA THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Mexico | 3 | |
#7 | Singapore | 3 | |
#8 | China | 2 | |
#9 | India | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Measurement | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Coish Philip D G | 22 |
#2 | Osterman David | 21 |
#3 | Blount Kenneth F | 18 |
#4 | Berman Judd | 18 |
#5 | Underwood Dennis | 17 |
#6 | Wilson Jeffrey | 17 |
#7 | Dixon Brian R | 15 |
#8 | Kaur Harpreet | 14 |
#9 | Navia Manuel | 14 |
#10 | Schostarez Heinrich J | 13 |
Publication | Filing date | Title |
---|---|---|
WO2013040412A2 | Methods for inhibiting bacteria growth | |
WO2012109458A1 | Flavin derivatives | |
EP2555623A1 | Flavin derivatives | |
EP2531223A2 | Novel methods and utilities | |
SG177323A1 | Flavin derivatives | |
EP2438194A1 | Methods for screening and identifying compounds | |
WO2010110907A1 | Diaminopteridine derivatives | |
KR20110097754A | Flavin derivatives |